Acquired Company
Pfizer acquired Seagen on 12/14/2023 for $229 in cash per share, for a total enterprise value of approximately $43 billion.
Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. On Dec. 14, 2023, Pfizer completed the acquisition of Seagen. Show more
Start AI Chat
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$228.74
Open
$228.74
Volume
N/A
Day Range
$228.74 - $228.74
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.81%
Institutional Own.
88.83%
Qtr Updated
09/30/24
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|